Symbiome
PrivateLast Round
VC Round
Oct 31, 2022
Total Funding Raised
$18M
Company Overview
Symbiome operates in Consumer & Commerce and is based in San Francisco, California. Its latest recorded funding round was a VC Round in October 2022.
Symbiome is a skincare company that produces science-based, microbiome-focused beauty products using sustainably sourced Amazonian ingredients.
Sector
Consumer & Commerce
Verticals
Fashion & Beauty, D2C Brands, Biotechnology
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symbiome Comparables
Compare Symbiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOBiome Therapeutics Inc. | 83% | |
| fjör | 83% | |
| Glowbiotics | 83% |
For institutional investors. Book with your work email.
Symbiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 31, 2022 | ||||
| Series A | Sep 14, 2020 | ||||
| Debt | Jun 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Symbiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GISEV | Series A |
| BOLD Capital Partners | Series A |
| True Ventures | Pre Seed, Series A |
| Mission Bay Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors increased 78% MoM, reaching 7.8K.
- May 2, 2025
Monthly visitors increased 76% to 15,000.
For institutional investors. Book with your work email.
Symbiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Symbiome's valuation, stock price, and market status.
Is Symbiome a public or private company?
Symbiome is a private company.
What is the current stock price of Symbiome?
Symbiome is a private company, so its shares have no public market price. Caplight tracks Symbiome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Symbiome worth (valuation)?
Valuation information for Symbiome is not publicly available.
Can I buy Symbiome stock?
Symbiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Symbiome's last funding round?
Symbiome's most recent funding round was VC Round on October 31, 2022.
Who are the main investors in Symbiome?
Key investors in Symbiome include True Ventures.
Will Symbiome IPO soon?
No public IPO plans have been announced for Symbiome.
How can I track Symbiome secondary market activity?
Caplight tracks bids, offers, and trades in Symbiome's shares on secondary markets.